MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

19 Oct 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release dated October 19, 2021 ‘Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..